bimekizumab
ucb pharmaceuticals
['bimekizumab', 'axspa']
0544. bimekizumab improves signs &amp; symptoms, including inflammation, in active nr-axspa: 24-week efficacy &amp; safety from a phase 3, multicenter rct 12s142. abstract session: spa treatment i
#acr22 #acrambassador
#rheumtwitter #medtwitter #spondyloarthritis 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books